Evaluation of Clinical Breast MR Imaging Performed with Prototype Computer-aided Diagnosis Breast MR Imaging Workstation: Reader Study
Akiko Shimauchi, Maryellen L. Giger, Neha Bhooshan, Li Lan, Lorenzo L. Pesce, John K. Lee, Hiroyuki Abe, and Gillian M. Newstead
Radiology 2011; 258 696-704
Link to Journal
Use of a diagnostic computer aid for dynamic contrast-enhanced MR imaging has the potential to improve radiologists' performance in differentiating between benign and malignant breast lesions
Wednesday, 2 March 2011
The Mammographic Density of a Mass Is a Significant Predictor of Breast Cancer
The Mammographic Density of a Mass Is a Significant Predictor of Breast Cancer
Ryan W. Woods, Gale S. Sisney, Lonie R. Salkowski, Kazuhiko Shinki, Yunzhi Lin, and Elizabeth S. Burnside
Radiology 2011; 258 417-425
Link to Journal
Our study shows that, in contrast to previous research, breast mass density is significantly associated with malignancy, even after controlling for other predictive variables
Ryan W. Woods, Gale S. Sisney, Lonie R. Salkowski, Kazuhiko Shinki, Yunzhi Lin, and Elizabeth S. Burnside
Radiology 2011; 258 417-425
Link to Journal
Our study shows that, in contrast to previous research, breast mass density is significantly associated with malignancy, even after controlling for other predictive variables
Breast Cancer: Early and Late Fluorescence Near-Infrared Imaging with Indocyanine Green: A Preliminary Study
Breast Cancer: Early and Late Fluorescence Near-Infrared Imaging with Indocyanine Green: A Preliminary Study
Alexander Poellinger, Susen Burock, Dirk Grosenick, Axel Hagen, Lutz Ludemann, Felix Diekmann, Florian Engelken, Rainer Macdonald, Herbert Rinneberg, and Peter-Michael Schlag
Radiology 2011; 258 409-416
Link to Journal
By capitalizing on the extravasation of indocyanine green (ICG) through the wall of tumorous vessels and consequently using late-fluorescence mammograms, we were able to achieve far more pronounced contrast between the tumorous and healthy background tissue (mean contrast value, 0.64) compared with this contrast on images acquired during or shortly after the administration of ICG (mean contrast value, 0.25)
Alexander Poellinger, Susen Burock, Dirk Grosenick, Axel Hagen, Lutz Ludemann, Felix Diekmann, Florian Engelken, Rainer Macdonald, Herbert Rinneberg, and Peter-Michael Schlag
Radiology 2011; 258 409-416
Link to Journal
By capitalizing on the extravasation of indocyanine green (ICG) through the wall of tumorous vessels and consequently using late-fluorescence mammograms, we were able to achieve far more pronounced contrast between the tumorous and healthy background tissue (mean contrast value, 0.64) compared with this contrast on images acquired during or shortly after the administration of ICG (mean contrast value, 0.25)
Labels:
breast cancer,
breast imaging,
fluorescence,
NIR
Multicenter, Double-Blind, Randomized, Intraindividual Crossover Comparison of Gadobenate Dimeglumine and Gadopentetate Dimeglumine for Breast MR Imaging (DETECT Trial)
Multicenter, Double-Blind, Randomized, Intraindividual Crossover Comparison of Gadobenate Dimeglumine and Gadopentetate Dimeglumine for Breast MR Imaging (DETECT Trial)
Laura Martincich, Matthieu Faivre-Pierret, Christian M. Zechmann, Stefano Corcione, Harrie C. M. van den Bosch, Wei-Jun Peng, Antonella Petrillo, Katja C. Siegmann, Johannes T. Heverhagen, Pietro Panizza, Hans-Bjorn Gehl, Felix Diekmann, Federica Pediconi, Lin Ma, Fiona J. Gilbert, Francesco Sardanelli, Paolo Belli, Marco Salvatore, Karl-Friedrich Kreitner, Claudia M. Weiss, and Chiara Zuiani
Radiology 2011; 258 396-408
Link to Journal
Gadobenate dimeglumine (0.1 mmol/kg) results in significantly (P [≤ ] . 0003) greater breast cancer detection rate and significantly (P [≤ ] . 0094) better diagnostic performance relative to that achieved with gadopentetate dimeglumine at an equivalent dose
Laura Martincich, Matthieu Faivre-Pierret, Christian M. Zechmann, Stefano Corcione, Harrie C. M. van den Bosch, Wei-Jun Peng, Antonella Petrillo, Katja C. Siegmann, Johannes T. Heverhagen, Pietro Panizza, Hans-Bjorn Gehl, Felix Diekmann, Federica Pediconi, Lin Ma, Fiona J. Gilbert, Francesco Sardanelli, Paolo Belli, Marco Salvatore, Karl-Friedrich Kreitner, Claudia M. Weiss, and Chiara Zuiani
Radiology 2011; 258 396-408
Link to Journal
Gadobenate dimeglumine (0.1 mmol/kg) results in significantly (P [≤ ] . 0003) greater breast cancer detection rate and significantly (P [≤ ] . 0094) better diagnostic performance relative to that achieved with gadopentetate dimeglumine at an equivalent dose
Reduction in False-Positive Results after Introduction of Digital Mammography: Analysis from Four Population-based Breast Cancer Screening Programs in Spain
Reduction in False-Positive Results after Introduction of Digital Mammography: Analysis from Four Population-based Breast Cancer Screening Programs in Spain
Maria Sala, Dolores Salas, Francesc Belvis, Mar Sanchez, Joana Ferrer, Josefa Ibanez, Ruben Roman, Francisco Ferrer, Alfonso Vega, Maria Soledad Laso, and Xavier Castells
Radiology 2011; 258 388-395
Link to Journal
While cancer detection did not differ in women screened with screen-film mammography (SFM) or digital mammography (DM), the recall rate and false-positive risk were lower with DM than with SFM after adjustment was made for the woman's screening mammogram, radiology unit screening round, age at screening, and time trends
Maria Sala, Dolores Salas, Francesc Belvis, Mar Sanchez, Joana Ferrer, Josefa Ibanez, Ruben Roman, Francisco Ferrer, Alfonso Vega, Maria Soledad Laso, and Xavier Castells
Radiology 2011; 258 388-395
Link to Journal
While cancer detection did not differ in women screened with screen-film mammography (SFM) or digital mammography (DM), the recall rate and false-positive risk were lower with DM than with SFM after adjustment was made for the woman's screening mammogram, radiology unit screening round, age at screening, and time trends
Utility of 6-month Follow-up Imaging after a Concordant Benign Breast Biopsy Result
Utility of 6-month Follow-up Imaging after a Concordant Benign Breast Biopsy Result
Lonie R. Salkowski, Amy M. Fowler, Elizabeth S. Burnside, and Gale A. Sisney
Radiology 2011; 258 380-387
Link to Journal
Six-month follow-up imaging for benign image-guided core biopsy results assessed as concordant with consensus review did not aid detection of breast cancers or influence recommended rebiopsy rates, suggesting that yearly follow-up may be more appropriate
Lonie R. Salkowski, Amy M. Fowler, Elizabeth S. Burnside, and Gale A. Sisney
Radiology 2011; 258 380-387
Link to Journal
Six-month follow-up imaging for benign image-guided core biopsy results assessed as concordant with consensus review did not aid detection of breast cancers or influence recommended rebiopsy rates, suggesting that yearly follow-up may be more appropriate
Labels:
benign biopsy,
concordance,
imaging follow up
Accuracy of Screening Mammography Varies by Week of Menstrual Cycle
Accuracy of Screening Mammography Varies by Week of Menstrual Cycle
Diana L. Miglioretti, Rod Walker, Donald L. Weaver, Diana S. M. Buist, Stephen H. Taplin, Patricia A. Carney, Robert D. Rosenberg, Mark B. Dignan, Zhuo (Tracy) Zhang, and Emily White
Radiology 2011; 258 372-379
Link to Journal
Among premenopausal women who had undergone mammography in the previous 2 years, mammography was more sensitive in the detection of breast cancer in those who underwent mammography during the 1st week of their menstrual cycle than in those who underwent mammography during the 2nd, 3rd, or 4th week of their menstrual cycle
Diana L. Miglioretti, Rod Walker, Donald L. Weaver, Diana S. M. Buist, Stephen H. Taplin, Patricia A. Carney, Robert D. Rosenberg, Mark B. Dignan, Zhuo (Tracy) Zhang, and Emily White
Radiology 2011; 258 372-379
Link to Journal
Among premenopausal women who had undergone mammography in the previous 2 years, mammography was more sensitive in the detection of breast cancer in those who underwent mammography during the 1st week of their menstrual cycle than in those who underwent mammography during the 2nd, 3rd, or 4th week of their menstrual cycle
Labels:
accuracy,
breast screening,
menstrual cycle,
variation
Dedicated Dual-Head Gamma Imaging for Breast Cancer Screening in Women with Mammographically Dense Breasts
Dedicated Dual-Head Gamma Imaging for Breast Cancer Screening in Women with Mammographically Dense Breasts
Deborah J. Rhodes, Carrie B. Hruska, Stephen W. Phillips, Dana H. Whaley, and Michael K. O'Connor
Radiology 2011; 258 106-118
Link to Journal
The addition of dedicated dual-head gamma imaging to screening mammography yielded significantly improved sensitivity while maintaining equivalent specificity in women with mammographically dense breasts
Deborah J. Rhodes, Carrie B. Hruska, Stephen W. Phillips, Dana H. Whaley, and Michael K. O'Connor
Radiology 2011; 258 106-118
Link to Journal
The addition of dedicated dual-head gamma imaging to screening mammography yielded significantly improved sensitivity while maintaining equivalent specificity in women with mammographically dense breasts
Labels:
dense breasts,
dual headed,
gamma imaging,
mammography
Risk of Radiation-induced Breast Cancer from Mammographic Screening
Risk of Radiation-induced Breast Cancer from Mammographic Screening
Martin J. Yaffe and James G. Mainprize
Radiology 2011; 258 98-105
Link to Journal
The predicted risk of radiation-induced breast cancer from mammographic screening is low in terms of the number of cancers induced, the number of potential deaths, and the number of woman-years of life lost
Martin J. Yaffe and James G. Mainprize
Radiology 2011; 258 98-105
Link to Journal
The predicted risk of radiation-induced breast cancer from mammographic screening is low in terms of the number of cancers induced, the number of potential deaths, and the number of woman-years of life lost
Combined Optical and X-ray Tomosynthesis Breast Imaging
Combined Optical and X-ray Tomosynthesis Breast Imaging
Qianqian Fang, Juliette Selb, Stefan A. Carp, Gregory Boverman, Eric L. Miller, Dana H. Brooks, Richard H. Moore, Daniel B. Kopans, and David A. Boas
Radiology 2011; 258 89-97
Link to Journal
Co-registered functional and structural image overlays demonstrate a significant difference in total hemoglobin concentration contrast between malignant tumors and solid benign lesions
Qianqian Fang, Juliette Selb, Stefan A. Carp, Gregory Boverman, Eric L. Miller, Dana H. Brooks, Richard H. Moore, Daniel B. Kopans, and David A. Boas
Radiology 2011; 258 89-97
Link to Journal
Co-registered functional and structural image overlays demonstrate a significant difference in total hemoglobin concentration contrast between malignant tumors and solid benign lesions
Labels:
breast imaging,
optical imaging,
tomosynthesis
Benign Papilloma without Atypia Diagnosed at US-guided 14-gauge Core-Needle Biopsy: Clinical and US Features Predictive of Upgrade to Malignancy
Benign Papilloma without Atypia Diagnosed at US-guided 14-gauge Core-Needle Biopsy: Clinical and US Features Predictive of Upgrade to Malignancy
Ji Hyun Youk, Eun-Kyung Kim, Jin Young Kwak, Eun Ju Son, Byeong-Woo Park, and Seung-Il Kim
Radiology 2011; 258 81-88
Link to Journal
Imaging-pathologic correlation, as well as patient age of 50 years or older, lesion size of 1 cm or greater, distance from nipple to lesion of 3 cm or greater, and Breast Imaging Reporting and Data System category may be helpful in predicting the likelihood of malignancy and in the management of benign papilloma without atypia after US-guided 14-gauge core-needle biopsy, while minimizing any delay in the diagnosis of cancer
Ji Hyun Youk, Eun-Kyung Kim, Jin Young Kwak, Eun Ju Son, Byeong-Woo Park, and Seung-Il Kim
Radiology 2011; 258 81-88
Link to Journal
Imaging-pathologic correlation, as well as patient age of 50 years or older, lesion size of 1 cm or greater, distance from nipple to lesion of 3 cm or greater, and Breast Imaging Reporting and Data System category may be helpful in predicting the likelihood of malignancy and in the management of benign papilloma without atypia after US-guided 14-gauge core-needle biopsy, while minimizing any delay in the diagnosis of cancer
Computer-aided Classification of Breast Masses: Performance and Interobserver Variability of Expert Radiologists versus Residents
Computer-aided Classification of Breast Masses: Performance and Interobserver Variability of Expert Radiologists versus Residents
Swatee Singh, Jeff Maxwell, Jay A. Baker, Jennifer L. Nicholas, and Joseph Y. Lo
Radiology 2011; 258 73-80
Link to Journal
Our study demonstrates that a computer-aided diagnosis model can potentially provide accurate classification of breast lesions for both radiology residents and experienced breast imagers with 3-17 years of experience
Swatee Singh, Jeff Maxwell, Jay A. Baker, Jennifer L. Nicholas, and Joseph Y. Lo
Radiology 2011; 258 73-80
Link to Journal
Our study demonstrates that a computer-aided diagnosis model can potentially provide accurate classification of breast lesions for both radiology residents and experienced breast imagers with 3-17 years of experience
Breast Cancer: Comparative Effectiveness of Positron Emission Mammography and MR Imaging in Presurgical Planning for the Ipsilateral Breast
Breast Cancer: Comparative Effectiveness of Positron Emission Mammography and MR Imaging in Presurgical Planning for the Ipsilateral Breast
Wendie A. Berg, Kathleen S. Madsen, Kathy Schilling, Marie Tartar, Etta D. Pisano, Linda Hovanessian Larsen, Deepa Narayanan, Al Ozonoff, Joel P. Miller, and Judith E. Kalinyak
Radiology 2011; 258 59-72
Link to Journal
Overall, 61 (16%) of 388 participants had an appropriate change in surgical management based on MR findings--more than the 41 (11%) participants with an appropriate change based on positron emission mammography (PEM) findings (P =. 003) and fewer than the 71 (18%) participants with an appropriate change based on combined PEM and MR findings (P =. 004 for comparison with MR imaging alone) ; 25 (6.4%) women had excessive excisions on the basis of MR findings compared with 19 (4.9%) women who had them on the basis of PEM findings (P =. 26) and 32 (8.2%) women who had them after undergoing combined PEM and MR imaging (P =. 023 for comparison with MR imaging alone)
Wendie A. Berg, Kathleen S. Madsen, Kathy Schilling, Marie Tartar, Etta D. Pisano, Linda Hovanessian Larsen, Deepa Narayanan, Al Ozonoff, Joel P. Miller, and Judith E. Kalinyak
Radiology 2011; 258 59-72
Link to Journal
Overall, 61 (16%) of 388 participants had an appropriate change in surgical management based on MR findings--more than the 41 (11%) participants with an appropriate change based on positron emission mammography (PEM) findings (P =. 003) and fewer than the 71 (18%) participants with an appropriate change based on combined PEM and MR findings (P =. 004 for comparison with MR imaging alone) ; 25 (6.4%) women had excessive excisions on the basis of MR findings compared with 19 (4.9%) women who had them on the basis of PEM findings (P =. 26) and 32 (8.2%) women who had them after undergoing combined PEM and MR imaging (P =. 023 for comparison with MR imaging alone)
Labels:
breast MRI,
Comparative effectiveness,
MRI,
PEM,
surgical planning
Subscribe to:
Posts (Atom)